146 related articles for article (PubMed ID: 33004755)
1. Clinicopathologic factors associated with pathologic upstaging in patients clinically diagnosed stage T2N0M0 squamous cell esophageal carcinoma.
Li M; Xie H; Zhen F; Wang H; Peng Z; Xu L
J Cancer Res Ther; 2020 Sep; 16(5):1106-1111. PubMed ID: 33004755
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between the Size of Metastatic Lymph Nodes and Positron Emission Tomographic/Computer Tomographic Findings in Patients with Esophageal Squamous Cell Carcinoma.
Park SY; Kim DJ; Jung HS; Yun MJ; Lee JW; Park CK
World J Surg; 2015 Dec; 39(12):2948-54. PubMed ID: 26324159
[TBL] [Abstract][Full Text] [Related]
3. Does [18F] fluorodeoxyglucose-positron emission tomography/computed tomography have a role in cervical nodal staging for esophageal squamous cell carcinoma?
Li B; Li N; Liu S; Li Y; Qian B; Zhang Y; He H; Chen X; Sun Y; Xiang J; Hu H; Chen H
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):544-550. PubMed ID: 31932053
[TBL] [Abstract][Full Text] [Related]
4. Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
Wu LL; Zhong JD; Zhu JL; Kang L; Huang YY; Lin P; Long H; Zhang LJ; Ma QL; Qiu LH; Ma GW
BMC Cancer; 2022 Jan; 22(1):118. PubMed ID: 35090428
[TBL] [Abstract][Full Text] [Related]
5. [Application value of CT examination of lymph node short diameter in evaluating cardia-left gastric lymph node metastasis in thoracic esophageal squamous cell carcinoma].
Li ZX; Liu XB; Li Y; Liang GH; Wang ZF; Zheng Y; Sun HB; Wang W; Song T; Xing WQ
Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):962-966. PubMed ID: 37968082
[No Abstract] [Full Text] [Related]
6. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
[TBL] [Abstract][Full Text] [Related]
7. Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma.
Sugawara K; Yamashita H; Uemura Y; Mitsui T; Yagi K; Nishida M; Aikou S; Mori K; Nomura S; Seto Y
Surgery; 2017 Oct; 162(4):846-856. PubMed ID: 28739092
[TBL] [Abstract][Full Text] [Related]
8. Potential value of CT-based comprehensive nomogram in predicting occult lymph node metastasis of esophageal squamous cell paralaryngeal nerves: a two-center study.
Xue T; Wan X; Zhou T; Zou Q; Ma C; Chen J
J Transl Med; 2024 Apr; 22(1):399. PubMed ID: 38689366
[TBL] [Abstract][Full Text] [Related]
9. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer.
Zhao F; Lu RX; Liu JY; Fan J; Lin HR; Yang XY; You SH; Wu QG; Qin XY; Liu Y; Zhen FX; Luo JH; Wang W
BMC Cancer; 2021 Jan; 21(1):22. PubMed ID: 33402129
[TBL] [Abstract][Full Text] [Related]
11. Quantitative parameters derived from dual-energy computed tomography for the preoperative prediction of early recurrence in patients with esophageal squamous cell carcinoma.
Liu Y; Cheng F; Wang L; Du L; Shen H; Wang X; Zeng Z; Liu D; Tao J; Wu J; Zhang J
Eur Radiol; 2023 Nov; 33(11):7419-7428. PubMed ID: 37314470
[TBL] [Abstract][Full Text] [Related]
12. Lymph node staging in esophageal squamous cell carcinoma: a comparative study of endoscopic ultrasonography versus computed tomography.
Takizawa K; Matsuda T; Kozu T; Eguchi T; Kato H; Nakanishi Y; Hijikata A; Saito D
J Gastroenterol Hepatol; 2009 Oct; 24(10):1687-91. PubMed ID: 19788609
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Pretreatment PET/CT Nodal Status on Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiation.
Chen JX; Lu TY; Fang HY; Lin YS; Lee JM
World J Surg; 2020 Jul; 44(7):2323-2331. PubMed ID: 32296872
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e759-65. PubMed ID: 21470788
[TBL] [Abstract][Full Text] [Related]
16. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
Lim CH; Park YJ; Shin M; Cho YS; Choi JY; Lee KH; Hyun SH
Clin Nucl Med; 2020 Mar; 45(3):e128-e133. PubMed ID: 31977480
[TBL] [Abstract][Full Text] [Related]
17. Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study.
Miyawaki Y; Sato H; Fujiwara N; Oya S; Sugita H; Hirano Y; Yamane T; Sakuramoto S; Okamoto K; Yamaguchi S; Koyama I
Int J Clin Oncol; 2020 Apr; 25(4):561-569. PubMed ID: 31867680
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of T3 stage esophageal squamous cell carcinoma in different parts based on enhanced CT radiomics.
Li XF; Wang Q; Duan SF; Yao B; Liu CY
Medicine (Baltimore); 2020 Aug; 99(32):e21470. PubMed ID: 32769880
[TBL] [Abstract][Full Text] [Related]
19. [Analysis on CT in diagnosis of lymph node metastasis of thoracic esophageal cancer with minimum diameter greater than 1 cm].
Wu HR; Liu CQ; Guo MF; Xu MQ; Mei XY
Zhonghua Wai Ke Za Zhi; 2019 Aug; 57(8):601-606. PubMed ID: 31422630
[No Abstract] [Full Text] [Related]
20. Application of Pathological Staging in Esophageal Squamous Cell Carcinoma.
Lam AK
Methods Mol Biol; 2020; 2129():19-31. PubMed ID: 32056167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
